9
Views
3
CrossRef citations to date
0
Altmetric
Review

Measuring quality of life in chronic pelvic pain syndrome

Pages 115-124 | Published online: 10 Jan 2014

References

  • Coons S. Health-related quality of life: let’s measure it appropriately. Clin. Ther.29(12), 2746–2747 (2007).
  • Gold M, Russell L, Weinstein M. Cost–Effectiveness in Health and Medicine. Oxford University Press, NY, USA (1996).
  • Guyatt GH, Osoba D, Wu AW, Wyrwich KW, Norman GR. Methods to explain the clinical significance of health status measures. Mayo Clin. Proc.77(4), 371–383 (2002).
  • Dubernard G, Rouzier R, David-Montefiore E, Bazot M, Darai E. Use of the SF-36 questionnaire to predict quality-of-life improvement after laparoscopic colorectal resection for endometriosis. Hum. Reprod.23(4), 846–851 (2008).
  • Fenton BW, Durner C, Fanning J. Frequency and distribution of multiple diagnoses in chronic pelvic pain related to previous abuse or drug-seeking behavior. Gynecol. Obstet. Invest.65(4), 247–251 (2008).
  • Ortiz DD. Chronic pelvic pain in women. Am. Fam. Physician77(11), 1535–1542 (2008).
  • Stones RW, Selfe SA, Fransman S, Horn SA. Psychosocial and economic impact of chronic pelvic pain. Baillieres Best Pract. Res. Clin. Obstet. Gynaecol.14(3), 415–431 (2000).
  • Cronbach LJ. Coefficient a and the internal structure of tests. Psychometrika16(3), 297–334 (1951).
  • Jones G, Jenkinson C, Kennedy S. Development of the short form endometriosis health profile questionnaire: the EHP-5. Qual. Life Res.13(3), 695–704 (2004).
  • Neelakantan D, Omojole F, Clark TJ, Gupta JK, Khan KS. Quality of life instruments in studies of chronic pelvic pain: a systematic review. J. Obstet. Gynaecol.24(8), 851–858 (2004).
  • Lee CE, Browell LM, Jones DL. Measuring health in patients with cervical and lumbosacral spinal disorders: is the 12-item short-form health survey a valid alternative for the 36-item short-form health survey? Arch. Phys. Med. Rehabil.89(5), 829–833 (2008).
  • Walters SJ, Brazier JE. Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D. Qual. Life Res.14(6), 1523–1532 (2005).
  • The WHOQoL Group. Development of the World Health Organization WHOQoL-Bref quality of life assessment. Psychol. Med.28(3), 551–558 (1998).
  • Naumann VJ, Byrne GJ. WHOQoL-Bref as a measure of quality of life in older patients with depression. Int. Psychogeriatr.16(2), 159–173 (2004).
  • Horng YS, Hwang YH, Wu HC et al. Predicting health-related quality of life in patients with low back pain. Spine30(5), 551–555 (2005).
  • Ohaeri JU, Olusina AK, Al-Abassi AH. Factor analytical study of the short version of the World Health Organization Quality of Life Instrument. Psychopathology37(5), 242–248 (2004).
  • Aigner M, Forster-Streffleur S, Prause W, Freidl M, Weiss M, Bach M. What does the WHOQoL-Bref measure? Measurement overlap between quality of life and depressive symptomatology in chronic somatoform pain disorder. Soc. Psychiatry Psychiatr. Epidemiol.41(1), 81–86 (2006).
  • Jamison RN, Fanciullo GJ, McHugo GJ, Baird JC. Validation of the short-form interactive computerized quality of life scale (ICQoL-SF). Pain Med.8(3), 243–250 (2007).
  • Reeve BB, Hays RD, Bjorner JB et al. Psychometric evaluation and calibration of health-related quality of life item banks: plans for the Patient-Reported Outcomes Measurement Information System (PROMIS). Med. Care45(5 Suppl. 1), S22–S31 (2007).
  • Cella D, Gershon R, Lai JS, Choi S. The future of outcomes measurement: item banking, tailored short-forms, and computerized adaptive assessment. Qual. Life Res.16(Suppl. 1), 133–141 (2007).
  • Garcia SF, Cella D, Clauser SB et al. Standardizing patient-reported outcomes assessment in cancer clinical trials: a patient-reported outcomes measurement information system initiative. J. Clin. Oncol.25(32), 5106–5112 (2007).
  • Mielenz T, Jackson E, Currey S, DeVellis R, Callahan LF. Psychometric properties of the Centers for Disease Control and Prevention Health-Related Quality of Life (CDC HRQoL) items in adults with arthritis. Health Qual. Life Outcomes4, 66 (2006).
  • Moriarty DG, Zack MM, Kobau R. The Centers for Disease Control and Prevention’s Healthy Days Measures – population tracking of perceived physical and mental health over time. Health Qual. Life Outcomes1, 37 (2003).
  • Colwell HH, Mathias SD, Pasta DJ, Henning JM, Steege JF. A health-related quality-of-life instrument for symptomatic patients with endometriosis: a validation study. Am. J. Obstet. Gynecol.179(1), 47–55 (1998).
  • Szendei G, Hernadi Z, Devenyi N, Csapo Z. Is there any correlation between stages of endometriosis and severity of chronic pelvic pain? Possibilities of treatment. Gynecol. Endocrinol.21(2), 93–100 (2005).
  • Kennedy S, Bergqvist A, Chapron C et al. ESHRE guideline for the diagnosis and treatment of endometriosis. Hum. Reprod.20(10), 2698–2704 (2005).
  • Abbott JA, Hawe J, Clayton RD, Garry R. The effects and effectiveness of laparoscopic excision of endometriosis: a prospective study with 2–5 year follow-up. Hum. Reprod.18(9), 1922–1927 (2003).
  • Harada T, Momoeda M, Taketani Y, Hoshiai H, Terakawa N. Low-dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo-controlled, double-blind, randomized trial. Fertil. Steril.90(5), 1583–1588 (2008).
  • Jenkinson C, Kennedy S, Jones G. Evaluation of the American version of the 30-item Endometriosis Health Profile (EHP-30). Qual. Life Res.17(9), 1147–1152 (2008).
  • Jones G, Jenkinson C, Taylor N, Mills A, Kennedy S. Measuring quality of life in women with endometriosis: tests of data quality, score reliability, response rate and scaling assumptions of the Endometriosis Health Profile Questionnaire. Hum. Reprod.21(10), 2686–2693 (2006).
  • Miller JD. Quantification of endometriosis-associated pain and quality of life during the stimulatory phase of gonadotropin-releasing hormone agonist therapy: a double-blind, randomized, placebo-controlled trial. Am. J. Obstet. Gynecol.182(6), 1483–1488 (2000).
  • Crosignani PG, Luciano A, Ray A, Bergqvist A. Subcutaneous depot medroxyprogesterone acetate versus leuprolide acetate in the treatment of endometriosis-associated pain. Hum. Reprod.21(1), 248–256 (2006).
  • Lyons SD, Chew SS, Thomson AJ et al. Clinical and quality-of-life outcomes after fertility-sparing laparoscopic surgery with bowel resection for severe endometriosis. J. Minim. Invasive Gynecol.13(5), 436–441 (2006).
  • Farrar JT, Pritchett YL, Robinson M, Prakash A, Chappell A. The clinical importance of changes in the 0 to 10 numeric rating scale for worst, least, and average pain intensity: analyses of data from clinical trials of duloxetine in pain disorders. J. Pain DOI:10.1016/j.jpain.2009.06.007 (2009) (Epub ahead of print).
  • Dworkin RH, Turk DC, Revicki DA et al. Development and initial validation of an expanded and revised version of the Short-form McGill Pain Questionnaire (SF-MPQ-2). Pain144(1–2), 35–42 (2009).
  • Laursen BS, Bajaj P, Olesen AS, Delmar C, Arendt-Nielsen L. Health related quality of life and quantitative pain measurement in females with chronic non-malignant pain. Eur. J. Pain9(3), 267–275 (2005).
  • Sepulcri Rde P, do Amaral VF. Depressive symptoms, anxiety, and quality of life in women with pelvic endometriosis. Eur. J. Obstet. Gynecol. Reprod. Biol.142(1), 53–56 (2009).
  • Cox L, Ayers S, Nala K, Penny J. Chronic pelvic pain and quality of life after laparoscopy. Eur. J. Obstet. Gynecol. Reprod. Biol.132(2), 214–219 (2007).
  • Tripp DA, Nickel JC, Fitzgerald MP, Mayer R, Stechyson N, Hsieh A. Sexual functioning, catastrophizing, depression, and pain, as predictors of quality of life in women with interstitial cystitis/painful bladder syndrome. Urology73(5), 987–992 (2009).
  • Desrochers G, Bergeron S, Khalife S, Dupuis MJ, Jodoin M. Fear avoidance and self-efficacy in relation to pain and sexual impairment in women with provoked vestibulodynia. Clin. J. Pain25(6), 520–527 (2009).
  • Nickel JC, Payne CK, Forrest J, Parsons CL, Wan GJ, Xiao X. The relationship among symptoms, sleep disturbances and quality of life in patients with interstitial cystitis. J. Urol.181(6), 2555–2561 (2009).
  • Riedl A, Schmidtmann M, Stengel A et al. Somatic comorbidities of irritable bowel syndrome: a systematic analysis. J. Psychosom. Res.64(6), 573–582 (2008).
  • Fenton BW. Limbic associated pelvic pain: a hypothesis to explain the diagnostic relationships and features of patients with chronic pelvic pain. Med. Hypotheses69(2), 282–286 (2007).
  • Sairanen J, Leppilahti M, Tammela TL et al. Evaluation of health-related quality of life in patients with painful bladder syndrome/interstitial cystitis and the impact of four treatments on it. Scand. J. Urol. Nephrol.43(3), 212–219 (2009).
  • Zaslau S, Riggs DR, Perlmutter AE, Jackson BJ, Osborne J, Kandzari SJ. Sexual dysfunction in patients with painful bladder syndrome is age related and progressive. Can. J. Urol.15(4), 4158–4162 (2008).
  • Spiegel BM. The burden of IBS: looking at metrics. Curr. Gastroenterol. Rep.11(4), 265–269 (2009).
  • Naliboff BD, Balice G, Mayer EA. Psychosocial moderators of quality of life in irritable bowel syndrome. Eur. J. Surg. (583 Suppl.), 57–59 (1998).
  • Spiegel B, Harris L, Lucak S et al. Developing valid and reliable health utilities in irritable bowel syndrome: results from the IBS PROOF Cohort. Am. J. Gastroenterol.104(8), 1984–1991 (2009).
  • Cain KC, Headstrom P, Jarrett ME et al. Abdominal pain impacts quality of life in women with irritable bowel syndrome. Am. J. Gastroenterol.101(1), 124–132 (2006).
  • Moyal-Barracco M, Lynch PJ. 2003 ISSVD terminology and classification of vulvodynia: a historical perspective. J. Reprod. Med.49(10), 772–777 (2004).
  • Chren MM, Lasek RJ, Flocke SA, Zyzanski SJ. Improved discriminative and evaluative capability of a refined version of Skindex, a quality-of-life instrument for patients with skin diseases. Arch. Dermatol.133(11), 1433–1440 (1997).
  • Goldstein AT, Burrows L. Vulvodynia. J. Sex. Med.5(1), 5–14 (2008).
  • Ponte M, Klemperer E, Sahay A, Chren MM. Effects of vulvodynia on quality of life. J. Am. Acad. Dermatol.60(1), 70–76 (2009).
  • Jelovsek JE, Walters MD, Barber MD. Psychosocial impact of chronic vulvovagina conditions. J. Reprod. Med.53(2), 75–82 (2008).
  • Arnold LD, Bachmann GA, Rosen R, Kelly S, Rhoads GG. Vulvodynia: characteristics and associations with comorbidities and quality of life. Obstet. Gynecol.107(3), 617–624 (2006).
  • Forth HL, Cramp MC, Drechsler WI. Does physiotherapy treatment improve the self-reported pain levels and quality of life of women with vulvodynia? A pilot study. J. Obstet. Gynaecol.29(5), 423–429 (2009).
  • Masheb RM, Lozano-Blanco C, Kohorn EI, Minkin MJ, Kerns RD. Assessing sexual function and dyspareunia with the Female Sexual Function Index (FSFI) in women with vulvodynia. J. Sex. Marital. Ther.30(5), 315–324 (2004).
  • Jarvis SK, Abbott JA, Lenart MB, Steensma A, Vancaillie TG. Pilot study of botulinum toxin type A in the treatment of chronic pelvic pain associated with spasm of the levator ani muscles. Aust. NZ J. Obstet. Gynaecol.44(1), 46–50 (2004).
  • Haggerty CL, Schulz R, Ness RB. Lower quality of life among women with chronic pelvic pain after pelvic inflammatory disease. Obstet. Gynecol.102(5 Pt 1), 934–939 (2003).
  • Addis IB, Van Den Eeden SK, Wassel-Fyr CL, Vittinghoff E, Brown JS, Thom DH. Sexual activity and function in middle-aged and older women. Obstet. Gynecol.107(4), 755–764 (2006).
  • Addis IB, Ireland CC, Vittinghoff E, Lin F, Stuenkel CA, Hulley S. Sexual activity and function in postmenopausal women with heart disease. Obstet. Gynecol.106(1), 121–127 (2005).
  • Derogatis LR, Rosen R, Leiblum S, Burnett A, Heiman J. The Female Sexual Distress Scale (FSDS): initial validation of a standardized scale for assessment of sexually related personal distress in women. J. Sex. Marital. Ther.28(4), 317–330 (2002).
  • Fenton BW, Palmieri P, Durner C, Fanning J. Quantification of abdominal wall pain using pain pressure threshold algometry in patients with chronic pelvic pain. Clin. J. Pain25(6), 500–505 (2009).
  • Tu FF, Fitzgerald CM, Kuiken T, Farrell T, Norman Harden R. Vaginal pressure-pain thresholds: initial validation and reliability assessment in healthy women. Clin. J. Pain24(1), 45–50 (2008).
  • Cella D, Yount S, Rothrock N et al. The Patient-Reported Outcomes Measurement Information System (PROMIS): progress of an NIH Roadmap cooperative group during its first two years. Med. Care45(5 Suppl. 1), S3–S11 (2007).
  • Jeffery DD, Tzeng JP, Keefe FJ et al. Initial report of the cancer Patient-Reported Outcomes Measurement Information System (PROMIS) sexual function committee: review of sexual function measures and domains used in oncology. Cancer115(6), 1142–1153 (2009).

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.